Stay updated on Safety and Activity of 177Lu-3BP-227 in Solid Tumours Clinical Trial
Sign up to get notified when there's something new on the Safety and Activity of 177Lu-3BP-227 in Solid Tumours Clinical Trial page.

Latest updates to the Safety and Activity of 177Lu-3BP-227 in Solid Tumours Clinical Trial page
- Check6 days agoChange DetectedAdded Revision: v3.3.4. Removed Revision: v3.3.3 from the page's revision notes.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedAdded a Locations section with a Texas site and updated the page to Revision: v3.3.3; removed the HHS Vulnerability Disclosure and the Texas Locations entry from the previous version.SummaryDifference0.2%

- Check55 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2. No substantive changes to the study details or related information.SummaryDifference0.0%

- Check63 days agoChange DetectedRemoved the government funding notice about potential delays and NIH operations; this is an administrative change with no impact on the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check77 days agoChange DetectedNo additions or deletions were detected for the Study Details page. The content remains focused on the study design, eligibility criteria, and outcome measures.SummaryDifference0.4%

- Check106 days agoChange DetectedThe page now includes a government-funding and operating-status notice and marks a new version (v3.2.0), replacing the previous v3.1.0.SummaryDifference2%

Stay in the know with updates to Safety and Activity of 177Lu-3BP-227 in Solid Tumours Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety and Activity of 177Lu-3BP-227 in Solid Tumours Clinical Trial page.